Ling Lin
Impact in
- Immunology top 10%
- interferon and immune responses
- Immune Cell Function and Interaction
- Immune Response and Inflammation
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
-
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
Papers in
- Immunology 12
- Immune Response and Inflammation 4
- interferon and immune responses 3
- Aquaculture disease management and microbiota 3
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 2
- Immune Cell Function and Interaction 2
- Co-authors
- Andrea Gerth (2 shared papers)Stanford L. Peng (2 shared papers)Narendra Wajapeyee (1 shared paper)Lihua Julie Zhu (1 shared paper)Claude Gazin (1 shared paper)Sanchita Bhatnagar (1 shared paper)Jianhong Ou (1 shared paper)Ching-Man Virbasius (1 shared paper)
- Journals
- BMC Infectious Diseases (2 papers)Gastroenterology (1 paper)Advanced Materials (1 paper)European Journal of Immunology (1 paper)International Immunopharmacology (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Ling Lin
19 papers receiving 619 citations
Ling Lin's Hit Papers
Peers
Comparison fields: 5 of 82
- Immunology 252
- Molecular Biology 215
- Biomaterials 38
- Cancer Research 38
- Molecular Medicine 13
Countries citing papers authored by Ling Lin
This map shows the geographic impact of Ling Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Lin more than expected).
Fields of papers citing papers by Ling Lin
This network shows the impact of papers produced by Ling Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Lin. The network helps show where Ling Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Ling Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 141 | |
| 2 | 2004 | 125 | |
| 3 | 2023 | 75 | |
| 4 | Nano drug delivery systems for advanced immune checkpoint blockade therapy Hit paper breakdown → | 2025 | 73 |
| 5 | 2024 | 46 | |
| 6 | 2015 | 44 | |
| 7 | 2020 | 34 | |
| 8 | 2004 | 25 | |
| 9 | 2013 | 23 | |
| 10 | 2011 | 13 | |
| 11 | 2022 | 7 | |
| 12 | 2021 | 7 | |
| 13 | 2020 | 3 | |
| 14 | 2025 | 2 | |
| 15 | 2023 | 2 | |
| 16 | [Effect of reduced glutathione as anti-leukemic immune adjuvant]. | 2006 | 2 |
| 17 | 2012 | 1 | |
| 18 | 2025 | 1 | |
| 19 | 2019 | 1 | |
| 20 | 2021 | 0 |
About Ling Lin
Ling Lin is a scholar working on Immunology, Molecular Biology, Biomedical Engineering, Virology and Oncology, having authored 21 papers that have together received 625 indexed citations. Recurring topics across this work include Immune Response and Inflammation (4 papers), interferon and immune responses (3 papers), Aquaculture disease management and microbiota (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers), Immune Cell Function and Interaction (2 papers), Peptidase Inhibition and Analysis (2 papers), HIV Research and Treatment (2 papers) and Nanoplatforms for cancer theranostics (2 papers). The work is most often cited by research in Immunology (252 citations), Molecular Biology (215 citations), Biomaterials (38 citations), Cancer Research (38 citations) and Molecular Medicine (13 citations). Ling Lin has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Andrea Gerth, Stanford L. Peng, Narendra Wajapeyee, Lihua Julie Zhu, Claude Gazin, Sanchita Bhatnagar, Jianhong Ou, Ching-Man Virbasius, Xiaochun Zhu and Michael R. Green. Their work appears in journals such as BMC Infectious Diseases, Gastroenterology, Advanced Materials, European Journal of Immunology and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.